31 related articles for article (PubMed ID: 28768083)
1. Lung epithelial-specific TRIP-1 overexpression maintains epithelial integrity during hyperoxia exposure.
Nyp MF; Mabry SM; Navarro A; Menden H; Perez RE; Sampath V; Ekekezie II
Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29484847
[TBL] [Abstract][Full Text] [Related]
2. [Research progress of the role of non-coding RNA in hyperoxia-induced acute lung injury].
Wang T; Yin G; Liu G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):430-434. PubMed ID: 38813641
[TBL] [Abstract][Full Text] [Related]
3. Oridonin supplementation in rabbits may help to improve the outcome of induced atherosclerosis via autophagy induction.
Sultan A; Mohammad B; Hadi N; Al-Shaibany A; Philip A; Jamil D; Al-Aubaidy H
Acta Biomed; 2023 Apr; 94(2):e2023015. PubMed ID: 37092629
[TBL] [Abstract][Full Text] [Related]
4. An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential.
Abdullah NA; Md Hashim NF; Ammar A; Muhamad Zakuan N
Molecules; 2021 Feb; 26(4):. PubMed ID: 33546106
[TBL] [Abstract][Full Text] [Related]
5. Solubility and Bioavailability Enhancement of Oridonin: A Review.
Zhang Y; Wang S; Dai M; Nai J; Zhu L; Sheng H
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947574
[TBL] [Abstract][Full Text] [Related]
6. Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy.
Patel P; Garala K; Singh S; Prajapati BG; Chittasupho C
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543115
[TBL] [Abstract][Full Text] [Related]
7. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.
Li X; Zhang CT; Ma W; Xie X; Huang Q
Front Pharmacol; 2021; 12():645824. PubMed ID: 34295243
[TBL] [Abstract][Full Text] [Related]
8. Herbal Active Ingredients: Potential for the Prevention and Treatment of Acute Lung Injury.
Yu WY; Gao CX; Zhang HH; Wu YG; Yu CH
Biomed Res Int; 2021; 2021():5543185. PubMed ID: 34258266
[TBL] [Abstract][Full Text] [Related]
9. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.
He YQ; Zhou CC; Yu LY; Wang L; Deng JL; Tao YL; Zhang F; Chen WS
Pharmacol Res; 2021 Jan; 163():105224. PubMed ID: 33007416
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast, a phosphodiesterase-4 inhibitor, improves hyperoxia-induced lung injury via anti-inflammation.
Cao HY; Yu TH; Han CH; Liu WW; Zhang PX; Tang P
Undersea Hyperb Med; 2020; 47(2):189-196. PubMed ID: 32574434
[TBL] [Abstract][Full Text] [Related]
11. Changes in angiotensin II and angiotensin-converting enzyme of different tissues after prolonged hyperoxia exposure.
Han CH; Zhang PX; Liu Y; Zheng J; Liu K; Wei D; Qiao T; Peng B; Liu W
Undersea Hyperb Med; 2017; 44(1):39-44. PubMed ID: 28768084
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperoxic acute lung injury with stem cell transplantation in murine models: a brief review.
Zhang H; Zhang P; Han C; Zhou F; Li L; Liu W
Undersea Hyperb Med; 2016; 43(4):437-445. PubMed ID: 28763173
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxic acute lung injury.
Kallet RH; Matthay MA
Respir Care; 2013 Jan; 58(1):123-41. PubMed ID: 23271823
[TBL] [Abstract][Full Text] [Related]
14. Oridonin protects the lung against hyperoxia-induced injury in a mouse model.
Liu Y; Zhang PX; Han CH; Wei D; Qiao T; Peng B; Liu K; Zheng J; Liu W
Undersea Hyperb Med; 2017; 44(1):33-38. PubMed ID: 28768083
[TBL] [Abstract][Full Text] [Related]
15. [Wedelolactone alleviates hyperoxia-induced acute lung injury by regulating ferroptosis].
Liu J; Qin S; Feng B; Chen M; Mei H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1177-1181. PubMed ID: 37987128
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
